GSK: Delaware Supreme Court agrees appeal over Zantac cancer case claim
GSK has consistently maintained that the expert testimony which claims that an ingredient in the antacid drug Zantac is linked to cancer cannot be relied upon - Delaware's highest court is allowing its appeal.